An announcement from Avecho Biotechnology Limited ( (AU:AVE) ) is now available.
Avecho Biotechnology Limited has issued 4,166,666 fully paid ordinary shares to employees under its Equity Incentive Plan at a deemed issue price of $0.006 per share. This issuance was conducted without disclosure to investors under Part 6D.2 of the Corporations Act, and the company confirms compliance with relevant provisions of the Corporations Act, indicating transparency and adherence to regulatory standards.
More about Avecho Biotechnology Limited
Avecho Biotechnology Limited develops and commercialises innovative Human and Animal Health products using its proprietary drug delivery system called Tocopheryl Phosphate Mixture (TPM®). TPM® is derived from Vitamin E using unique, proprietary and patented processes and is proven to enhance the solubility and oral, dermal and transdermal absorption of drugs and nutrients. Avecho’s major projects include delivering TPM® enhanced injectable, oral and topical products for the human health market and is also developing TPM® to enhance the feed efficiency and health of livestock.
Current Market Cap: A$12.68M
See more insights into AVE stock on TipRanks’ Stock Analysis page.